Alias
科研级 Metelimumab ( 美替木单抗 ), Anti-TGFB1 Recombinant Antibody, Research Grade Metelimumab
Molecular Name
Metelimumab
Applications
IF, IP, Neut, FuncS, ELISA, FC, ICC
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
TGFB1[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. It was dropped from further development in favour of fresolimumab, which was being developed by Genzyme as of 2006.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。